Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,776 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Perforin Acts as an Immune Regulator to Prevent the Progression of NAFLD.
Wang Q, Li D, Zhu J, Zhang M, Zhang H, Cao G, Zhu L, Shi Q, Hao J, Wen Q, Liu Z, Yang H, Yin Z. Wang Q, et al. Among authors: hao j. Front Immunol. 2020 May 22;11:846. doi: 10.3389/fimmu.2020.00846. eCollection 2020. Front Immunol. 2020. PMID: 32528465 Free PMC article.
Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer.
Xu Y, Xiang Z, Alnaggar M, Kouakanou L, Li J, He J, Yang J, Hu Y, Chen Y, Lin L, Hao J, Li J, Chen J, Li M, Wu Q, Peters C, Zhou Q, Li J, Liang Y, Wang X, Han B, Ma M, Kabelitz D, Xu K, Tu W, Wu Y, Yin Z. Xu Y, et al. Among authors: hao j. Cell Mol Immunol. 2021 Feb;18(2):427-439. doi: 10.1038/s41423-020-0515-7. Epub 2020 Sep 16. Cell Mol Immunol. 2021. PMID: 32939032 Free PMC article.
Allogeneic Vγ9Vδ2 T-Cell Therapy Promotes Pulmonary Lesion Repair: An Open-Label, Single-Arm Pilot Study in Patients With Multidrug-Resistant Tuberculosis.
Liang J, Fu L, Li M, Chen Y, Wang Y, Lin Y, Zhang H, Xu Y, Qin L, Liu J, Wang W, Hao J, Liu S, Zhang P, Lin L, Alnaggar M, Zhou J, Zhou L, Guo H, Wang Z, Liu L, Deng G, Zhang G, Wu Y, Yin Z. Liang J, et al. Among authors: hao j. Front Immunol. 2021 Dec 15;12:756495. doi: 10.3389/fimmu.2021.756495. eCollection 2021. Front Immunol. 2021. PMID: 34975844 Free PMC article. Clinical Trial.
CFTR is a negative regulator of γδ T cell IFN-γ production and antitumor immunity.
Duan Y, Li G, Xu M, Qi X, Deng M, Lin X, Lei Z, Hu Y, Jia Z, Yang Q, Cao G, Liu Z, Wen Q, Li Z, Tang J, Zhang WK, Huang P, Zheng L, Flavell RA, Hao J, Yin Z. Duan Y, et al. Among authors: hao j. Cell Mol Immunol. 2021 Aug;18(8):1934-1944. doi: 10.1038/s41423-020-0499-3. Epub 2020 Jul 15. Cell Mol Immunol. 2021. PMID: 32669666 Free PMC article.
Roles of mTORC1 and mTORC2 in controlling γδ T1 and γδ T17 differentiation and function.
Yang Q, Liu X, Liu Q, Guan Z, Luo J, Cao G, Cai R, Li Z, Xu Y, Wu Z, Xu M, Zhang S, Zhang F, Yang H, Lin X, Yang M, Wu Y, Gao Y, Flavell R, Hao J, Yin Z. Yang Q, et al. Among authors: hao j. Cell Death Differ. 2020 Jul;27(7):2248-2262. doi: 10.1038/s41418-020-0500-9. Epub 2020 Jan 30. Cell Death Differ. 2020. PMID: 32001780 Free PMC article.
6,776 results